Carfilzomib is an injectable drug that impedes the ability of cancer cells to produce and destroy proteins, preventing them from multiplying quickly, which slows down the development of cancer.
Thus, this remedy is used in combination with dexamethasone and lenalidomide to treat cases of multiple myeloma, a type of bone marrow cancer.
The commercial name of this medicine is Kyprolis and, although it can be bought in conventional pharmacies with the presentation of a prescription, it should only be administered in the hospital with the supervision of a doctor with experience in the treatment of cancer.
What is it for
This medicine is indicated for the treatment of adults with multiple myeloma who have received at least one type of previous treatment. Carfilzomib should be used in combination with dexamethasone and lenalidomide.
How to use
Carfilzomib can only be administered at the hospital by a doctor or nurse, the recommended dose of which varies according to each person's body weight and the body's response to treatment
This remedy must be administered directly into the vein for 10 minutes on two consecutive days, once a week and for 3 weeks. After these weeks, you should take a 12-day break and start another cycle if necessary.
Possible side effects
Some of the most common side effects include dizziness, headaches, insomnia, decreased appetite, increased blood pressure, shortness of breath, vomiting cough, diarrhea, constipation, abdominal pain, nausea, joint pain, muscle spasms, excessive tiredness and even fever,
In addition, there may also be cases of pneumonia and other constant respiratory infections, as well as changes in blood test values, especially in the number of leukocytes, erythrocytes and platelets.
Who should not use
Carfilzomib should not be used by pregnant or breastfeeding women, as well as in people who are allergic to any of the components of the formula. In addition, it should be used with care and only under medical advice in case of heart disease, lung problems or kidney disorders.
